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Abstract
Objectives—Drugged driving [DD] is a public health concern, particularly among emerging 
adults who have the highest rates of drug use. Understanding involvement with DD could inform 
prevention efforts for this population. We evaluated the prevalence of, motives for, and correlates 
of past-year DD among emerging adults from an urban, under-resourced community.
Methods—Emerging adults (N=586) ages 18–25 years (54% male, 56% African American, 34% 
European American) seeking care in an urban emergency department completed past-year surveys 
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of demographics, frequency of DD within 4 hours of substance use, reasons for DD, and substance 
use.
Results—DD was reported by 24% of participants (with 25% of those engaging in high 
frequency DD). DD after cannabis use was most common (96%), followed by prescription 
opioids, sedatives, and stimulants (9%–19%). Common reasons for DD were: needing to go home 
(67%), not thinking drugs affected driving ability (44%), not having to drive far (33%), and not 
feeling high (32%). Demographics were not associated with DD, but, as expected, those with DD 
had riskier substance use.
Conclusions—In this clinical sample, using a conservative measure, DD, particularly following 
cannabis use, was relatively common among emerging adults. Based on these data, clinical 
interventions for cannabis and other drug use should include content on prevention of DD, with 
particular attention to motives such as planning ahead for alternatives to get home safely and 
weighing benefits and risks of DD.
Keywords
impaired driving; emerging adults; drug use
1. Introduction
Driving under the influence of drugs (i.e., drugged driving [DD]) is a growing public health 
problem, particularly because 16% of fatal motor vehicle crashes are associated with drug 
use (Centers for Disease Control and Prevention, 2016). Although there is much research on 
alcohol-impaired driving, less is known about DD. Emerging adults (e.g., ages 18–25 years) 
are an important population to study regarding DD due to their high rates of drug use. 
Nationally, in the past year, 38% have used illicit drugs, with cannabis being most frequently 
used, and 10% reporting DD (Center for Behavioral Health Statistics and Quality, 2016). In 
regional samples, rates ranged from 15%–53% for driving after cannabis use or non-medical 
use of prescription drugs (Benotsch et al., 2015; Caldeira, Arria, O'Grady, Vincent, & Wish, 
2008; Whitehill, Rivara, & Moreno, 2014). The distinctive role of delta-9-
tetrahydrocannabinol (THC; the psychoactive compound in cannabis), the most frequently 
detected drug in motor vehicle crashes, is difficult to ascertain (National Institute on Drug 
Abuse, 2017); studies show a connection between THC, delayed responses to road obstacles, 
and diminished driving performance (Downey et al., 2013; Liguori, Gatto, & Robinson, 
1998; Ramaekers, Berghaus, van Laar, & Drummer, 2004). Further, a recent review of 
experimental studies concluded that benzodiazepines, opioids, cannabis, and other drugs 
cause negative effects on psychomotor functions implicated in driving (Strand, Gjerde, & 
Morland, 2016). Understanding factors associated with DD is important considering 
emerging adults engage in this high-risk behavior despite potentially fatal consequences.
Along with the development of alcohol per se laws (Giesbrecht & Greenfield, 2003), brief 
interventions for young people show desirable outcomes for reducing alcohol-impaired 
driving (Steinka-Fry, Tanner-Smith, & Hennessy, 2015), but it is unknown the extent to 
which such interventions address DD. More data are needed to inform policy and 
interventions targeting DD in emerging adults, particularly to prevent consequences of 
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cannabis-impaired driving given increasing potency (ElSohly et al., 2016) and changes in 
access due to medical and recreational legalization in the US. Motives for DD could be 
important factors in interventions, but these have not been studied. The emergency 
department (ED) is a potential clinical setting for interventions with previous studies 
showing that ED-based brief interventions reduced drug use and consequences (Blow et al., 
2017; Woolard et al., 2013). To inform interventions by addressing a gap in the literature 
about reasons for DD, we assessed the prevalence of and motivations for DD among 18–25 
year-olds seeking care in an urban ED and evaluated demographics and substance use 
correlates of DD.
2. Method
2.1 Procedures
From November 2014 to September 2015, patients aged 18–25 years were recruited from the 
ED at Hurley Medical Center (HMC), a Level-1 trauma center serving urban Flint, 
Michigan. As part of recruitment for a longitudinal study (Bonar et al., 2017), participants 
were identified via ED medical records and provided written informed consent to screen for 
the study. Exclusion criteria (detailed elsewhere; Bonar et al., 2017) generally included 
conditions that would preclude informed consent or ED visit involving intensive social work 
(e.g., sexual assault or suicidal ideation). Compensation was a token gift (e.g., lotion, 
notepads) for self-administering the computerized 15–20-minute screener. Institutional 
review boards at HMC and the University of Michigan approved the study. A Certificate of 
Confidentiality was provided by the National Institutes of Health.
2.2 Participants
We approached 726 patients for screening; 81% (N = 586) participated. Those refusing 
screening (19%) did not differ from screened participants based on age (t[724] = 1.35, p = 
0.18) or gender (χ2[1] = 0.0, p = .99). Enrolled participants’ mean age was 21.7 years (SD = 
1.1); 54% were male, 56% were African American, 34% European American, and 10% of 
other backgrounds. About half (48%) were receiving public assistance. See Table 1 for 
further demographics.
2.3 Measures
2.3.1 Demographics—Items were adapted from national surveys (Johnston, Bachman, 
O'Malley, & Schulenberg, 2011; United States Department of Health and Human Services, 
National Institutes of Health, & National Institute on Drug Abuse, 2008) to assess 
demographics (e.g., age, sex, race).
2.3.2 Substance Use—Based on the NIDA-Modified Alcohol Smoking and Substance 
Involvement Screening Test (ASSIST; WHO ASSIST Working Group, 2002), we assessed 
frequency of past-year use of cannabis, prescription sedatives, stimulants, opioids/pain 
relievers; cocaine, methamphetamine, street opioids, hallucinogens, and inhalants. We report 
drug use frequency variables for cannabis and prescription drug misuse using these response 
options: never, once or twice, monthly, weekly, daily/or almost daily (coded 0 to 4, 
respectively, for analyses). The remaining five drugs were combined into “Yes” to any 
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versus “No” due to lower frequency. Tobacco use was assessed dichotomously. The 
CRAFFT screening tool (Knight et al., 1999) characterized substance use risk in the sample 
(α = .79) and the AUDIT-C (Bush, Kivlahan, McDonell, Fihn, & Bradley, 1998) assessed 
hazardous drinking (α = .85)
2.3.3. Drugged Driving—Based on drugs assessed in the NIDA-Modified ASSIST, we 
listed the same nine drugs listed above, followed by an item we developed, “In the past 12 
months, how many times did you drive within four hours after using any of the drugs 
above?” with responses: Never, 1–2 times, 3–5 times, 6–10 times, and 10+ times. Those 
responding affirmatively were asked: “Think about all the times in the past 12 months you 
drove within 4 hours after using any drugs. Which drugs did you use in those 4 hours before 
driving?” Response options included the same nine drugs and participants could check all 
that applied. We chose the 4-hour window for drugged driving after consumption as a gross 
measure of potential impairment because the range of substances assessed can differentially 
impact driving-related functions depending on dose and half-life (e.g., psychomotor effects 
of cannabis can last up to 8 hours; Neavyn, Blohm, Babu, & Bird, 2014). Based on alcohol-
impaired driving research (Basch, DeCicco, & Malfetti, 1989; Kulick & Rosenberg, 2000; 
Rosenberg, 1988), we developed 16 reasons for DD (Table 2) and asked participants, for the 
past year, to choose all the reasons they had “decided to drive within 4 hours of using 
drugs.”
2.4 Data analysis
We used SAS version 9.4 for descriptive statistics, chi-square analyses, and independent 
samples t-tests to examine associations among past-year DD (collapsed to binary: yes/no), 
demographics, and substance use characteristics. Among those with DD, we repeated these 
analyses comparing those with high frequency DD (10+ times) to lower frequency DD.
3. Results
Of the 586 participants surveyed, 24% (n=138) reported past-year DD. Among those 138 
who reported past-year DD, the frequency was as follows: 1–2 times = 48%, 3–5 times = 
15%, 6–10 times = 12%, and 10+ times (i.e., high frequency DD) = 25%. Among substances 
used prior to past-year DD, cannabis was most frequent (96%) followed by misuse of 
prescriptions: opioids (19%), sedatives/sleeping pills (9%), and stimulants (9%). Other drugs 
were infrequently reported (cocaine = 5%, street opioids = 4%, hallucinogens = 3%, 
methamphetamine = 1%, inhalants = 0%). Table 1 also displays comparisons between those 
who reported DD and those who did not. The two groups did not differ on any demographic 
characteristics assessed: age, gender, race, marital status, current school enrollment, highest 
education level, public assistance, and having children (ps > .05). As might be expected, 
compared to those not reporting DD, those reporting any DD had significantly higher use of 
cannabis and misuse of prescription opioids, sedatives, and stimulants and were more likely 
to report other drug use, tobacco use, and had higher CRAFFT and AUDIT-C scores. Drug 
use and CRAFFT scores also distinguished those with higher frequency DD from those with 
less frequent DD.
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Reasons for DD are shown in Table 2. Most participants (65%) selected more than one 
reason (M = 3.3 reasons, SD = 2.8). The most common reasons for DD were: needing to go 
home (67%); not thinking drugs had affected driving ability (44%); not having to drive very 
far (33%); and, not feeling high (32%). The lowest number of participants (3%) endorsed 
purposefully wanting to take a risk. Only 4% reported that they did not remember the reason 
for driving due to a blackout. Seven reasons were selected by a significantly higher 
proportion of those with high frequency DD compared to those with lower frequency DD 
(Table 2).
4. Discussion
We sought to fill a gap in the literature regarding emerging adults’ motivations for DD, 
which can aid in the development of intervention and prevention programs for clinical 
settings, such as the ED. Among emerging adults sampled in an urban ED, approximately 1 
in 4 reported past-year DD. Second to cannabis, which was used prior to DD among 96% of 
those reporting DD, misuse of prescription drugs precipitated DD for nearly 20%. The rate 
of DD was more than twice that reported in national data during a similar time frame 
(Center for Behavioral Health Statistics and Quality, 2016); differences in measurement, or 
the increased rates of cannabis use in clinical samples and/or urban communities (Hasin et 
al., 2015) may account for this discrepancy. Regardless, these findings highlight the need for 
interventions to prevent DD among emerging adults, particularly those using cannabis. 
Notably, demographic factors did not distinguish individuals reporting DD. As might be 
expected, those reporting more frequent and severe substance use were more likely to 
indicate DD, supporting the integration of DD prevention into substance use interventions.
Participants chose, on average, at least three reasons for DD. They commonly reported DD 
because they needed to go home, did not have to go far, and because they did not perceive 
any impairment or think their driving ability would be affected. Without more fine-grained 
detail on potency, dose, timing of substance use, and co-ingestion with alcohol or other 
drugs prior to driving, it is unclear whether participants’ subjective assessments of lack of 
impairment were accurate. About one-quarter engaged in DD because driving high was not 
perceived as being as dangerous as driving drunk. This is consistent with prior research 
indicating that cannabis is perceived as less risky than alcohol (Lau et al., 2015), general 
decreasing trends in cannabis risk perceptions (Lipari, 2013), and low risk perceptions of 
driving after non-medical use of prescription drugs (Benotsch et al., 2015). The 15% of 
participants who did not think they would get caught for DD were perhaps accurate given 
that at the time of this study their state of residence did not enforce roadside saliva drug 
screening. Our findings regarding the perception that DD is low risk could relate to the fact 
that no guidelines exist for “safe” levels of intoxication or lengths of time to wait prior to 
driving once cannabis or other drugs are consumed; thus, making it difficult to determine 
when it is “safe” to drive. Other endorsed motives reflected a perceived necessity to drive 
(e.g., having an emergency, being relied upon by others for a ride) or convenience (e.g., 
easier to drive than take the bus).
Discrepancies in traffic studies regarding the effects of drug presence versus drug 
intoxication can make it difficult to make inferences about the connection between crash risk 
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and intoxication (Berning & Smither, 2014). Participants’ selection of reasons such as 
convenience, perceived necessity, and their beliefs that driving ability is unaffected by drugs 
may be a function of these inconsistencies. Studies suggest that drug presence increases the 
odds of motor vehicle crashes (Berning & Smither, 2014; Compton & Berning, 2009), but 
drug presence may not equate to impairment and potentially increases the inconsistency in 
reports of crash risk (Berning & Smither, 2014). This is especially true in the case of 
cannabis, where inconsistent reports of crash risk based on epidemiological studies versus 
laboratory studies as well as unclear legal standards regarding impairment continue to 
burden policy-makers (DuPont, Logan, Shea, Talpins, & Voas, 2011; Huestis, 2015). Note 
also that our data were collected in a state with legal medical cannabis, but not legal 
recreational cannabis, and rates of DD could vary across states with different cannabis 
policies (Salomonsen-Sautel, Min, Sakai, Thurstone, & Hopfer, 2014).
Despite the new information provided by this study, there were limitations. These include 
reliance on cross-sectional, retrospective, self-report data that may be subject to response 
biases and inhibit causal interpretations. There is potential limited generalizability to other 
populations outside urban hospital settings. Further, compared to a national survey (Center 
for Behavioral Health Statistics and Quality, 2016) querying driving “under the influence” 
our conservative 4-hour window for assessing DD may have over-estimated impaired driving 
due to variation in how different substances alter motor coordination or reaction time. 
Knowing that it would be impossible to retrospectively assess impairment (which would be 
best measured through laboratory and performance-based measures), we chose this 4-hour 
window to create a gross measure of possible impairment from a range of substances that 
metabolize at different rates. Although limited in some respects, this method improves 
somewhat upon assessments of driving “after” consumption (Caldeira et al., 2008; Whitehill 
et al., 2014) and also does not rely on subjective reports of whether the participants were 
“under the influence.” Event-based methods (Stone, Shiffman, Atienza, & Nebeling, 2007) 
are suggested for future research examining quantity, co-ingestion, and temporal sequencing 
of substance use, and motivations, with DD. It is also possible that our data underestimate 
DD given we did have information regarding whether participants had a driver’s license or 
access to a vehicle, which should be considered in future research.
Given the prevalence, interventions addressing DD are a logical next step, and may be 
delivered in the ED or other settings where high-risk emerging adults present. Although 
participants reported an average of three motives for DD, interventions should likely be 
tailored to unique, and possibly situationally-specific, combinations of motives. Several 
reasons distinguished those reporting more frequent DD (25% of those with DD) compared 
to less frequent DD. These reasons (e.g., perceiving that DD is not dangerous, not thinking 
drugs had affected driving ability, needing to leave, or being the designated driver) may be 
key intervention targets for those with riskier profiles, particularly because these participants 
also had higher severity scores on the CRAFFT and were more likely to use drugs other than 
cannabis and prescriptions. Low perceptions of dangerousness and impairment as reasons 
for DD are important for future investigations with high-risk participants, because they were 
endorsed more frequently and could reflect unique patterns of drug use that may be more or 
less risky. In general, psychoeducation in conjunction with motivational approaches (e.g., the 
motivational interviewing strategy: Elicit-Provide-Elicit; Miller & Rollnick, 2012) targeting 
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discrepant beliefs surrounding the ways in which drugs can impair reaction time or 
coordination may be helpful in reducing DD behaviors. Providing resources for and 
developing planning skills for obtaining safe rides (e.g., mobile transportation apps, public 
transportation, designating a driver) may also be useful if tailored to individual motivation 
and access.
The passing of alcohol per se laws (Giesbrecht & Greenfield, 2003) and intervention/
prevention efforts have contributed to decreasing the public health impact of alcohol-
impaired driving (Steinka-Fry et al., 2015), thus developing similar policies, informed by 
experimental data on impairment associated with various levels of consumption and/or co-
ingestion, along with intervention/prevention programs targeting motives for drug use has 
the potential to successfully promote the use of protective behaviors that reduce DD among 
emerging adults.
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Highlights
• Past-year drugged driving was common in emerging adults in an emergency 
department.
• Cannabis use was most frequent prior to drugged driving.
• The most common reason for drugged driving was needing to go home.
• The second most common reason was not thinking drugs had affected driving 
ability.
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Table 2
Reasons for drugged driving based on participants’ frequency of drugged driving in the past year
Total Sample
N=138
Lower
Frequency DD
N=103
High
Frequency DD
N=35
% (N) % (N) % (N)
Reasons for drugged driving (check all that apply)
I needed to go home or somewhere else* 67% (92) 61% (63) 83% (29)
I did not think the drugs had affected my ability to drive safely* 44% (61) 39% (40) 60% (21)
I did not have to drive very far 33% (45) 32% (33) 34% (12)
I did not feel high 32% (44) 29% (30) 40% (14)
Driving high does not seem as dangerous as driving drunk** 25% (35) 19% (20) 43% (15)
I did not think driving would be dangerous*** 22% (31) 15% (15) 46% (16)
I was the only one who had a car 20% (28) 18% (19) 26% (9)
Driving was more convenient than walking, taking a bus, or getting another ride** 19% (26) 14% (14) 34% (12)
I did not think I would get caught for driving high* 15% (21) 11% (11) 29% (10)
I was the designated driver* 14% (19) 10% (10) 26% (9)
Others wanted me to drive them somewhere 12% (16) 9% (9) 20% (7)
I had an emergency and had to get there quickly 10% (14) 9% (9) 14% (5)
I had used less than all the other people who could drive 7% (10) 8% (8) 6% (2)
There were not a lot of other people driving at that time of day or night 4% (5) 3% (3) 6% (2)
I don’t remember why I drove because I was blacked out 4% (5) 2% (2) 9% (3)
I wanted to take a risk 3% (4) 2% (2) 6% (2)
*p<.05,
**p<.01,
***p<.001
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